Cargando…

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma

Current treatments for cholangiocarcinoma (CCA) are largely unsuccessful due to late diagnosis at advanced stage, leading to high mortality rate. Consequently, improved therapeutic approaches are urgently needed. Chimeric antigen receptor (CAR) T cell therapy is a newly potential therapy that can re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Supimon, Kamonlapat, Sangsuwannukul, Thanich, Sujjitjoon, Jatuporn, Phanthaphol, Nattaporn, Chieochansin, Thaweesak, Poungvarin, Naravat, Wongkham, Sopit, Junking, Mutita, Yenchitsomanus, Pa-thai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973425/ https://www.ncbi.nlm.nih.gov/pubmed/33737613 http://dx.doi.org/10.1038/s41598-021-85747-9

Ejemplares similares

Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
por: Sangsuwannukul, Thanich, et al.
Publicado: (2022)

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells
por: Phanthaphol, Nattaporn, et al.
Publicado: (2021)

Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
por: Wathikthinnakon, Methi, et al.
Publicado: (2022)

Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains
por: Wutti-in, Yupanun, et al.
Publicado: (2022)

Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens
por: Chieochansin, Thaweesak, et al.
Publicado: (2019)

High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients’ samples
por: Phikulsod, Ployploen, et al.
Publicado: (2023)

Estradiol Prevents High Glucose-Induced β-cell Apoptosis by Decreased BTG2 Expression
por: Kooptiwut, Suwattanee, et al.
Publicado: (2018)

Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells
por: Junking, Mutita, et al.
Publicado: (2020)

Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein
por: Luangwattananun, Piriya, et al.
Publicado: (2022)

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction
por: Sujjitjoon, Jatuporn, et al.
Publicado: (2020)

Alpha-mangostin inhibits viral replication and suppresses nuclear factor kappa B (NF-κB)-mediated inflammation in dengue virus infection
por: Tarasuk, Mayuri, et al.
Publicado: (2022)

Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors
por: Sawasdee, Nunghathai, et al.
Publicado: (2022)

Adaptor Protein 1A Facilitates Dengue Virus Replication
por: Yasamut, Umpa, et al.
Publicado: (2015)

Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
por: Chuangchot, Nisa, et al.
Publicado: (2023)

Dopachrome tautomerase is a retinoblastoma-specific gene, and its proximal promoter is preferentially active in human retinoblastoma cells
por: Moolsuwan, Kanya, et al.
Publicado: (2022)

Targeting UCHL1 Induces Cell Cycle Arrest in High-Risk Multiple Myeloma with t(4;14)
por: Kamseng, Parin, et al.
Publicado: (2021)

Novel Adiponectin Variants Identified in Type 2 Diabetic Patients Reveal Multimerization and Secretion Defects
por: Jungtrakoon, Prapaporn, et al.
Publicado: (2011)

Mesothelin-specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3-treated self-differentiated dendritic cells
por: Jirapongwattana, Niphat, et al.
Publicado: (2022)

A Novel Predictive Equation for Potential Diagnosis of Cholangiocarcinoma
por: Kraiklang, Ratthaphol, et al.
Publicado: (2014)

Establishment and characterization of novel highly aggressive HER2-positive and triple-negative breast cancer cell lines
por: Thongchot, Suyanee, et al.
Publicado: (2021)

Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells
por: Sumransub, Nuttavut, et al.
Publicado: (2020)

Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis
por: Phanthaphol, Nattaporn, et al.
Publicado: (2017)

High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
por: Saengboonmee, Charupong, et al.
Publicado: (2016)

A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin
por: Teeravirote, Karuntarat, et al.
Publicado: (2021)

Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma
por: Yosudjai, Juthamas, et al.
Publicado: (2019)

Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma
por: Obchoei, Sumalee, et al.
Publicado: (2011)

Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma
por: Sribenja, Sirinapa, et al.
Publicado: (2013)

Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells
por: Chiawpanit, Chutipa, et al.
Publicado: (2022)

Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB
por: Phoomak, Chatchai, et al.
Publicado: (2016)

High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation
por: Phoomak, Chatchai, et al.
Publicado: (2017)

High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
por: Thonsri, Unchalee, et al.
Publicado: (2020)

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells
por: Seubwai, Wunchana, et al.
Publicado: (2016)

Inhibitory Effect of Aspirin on Cholangiocarcinoma Cells
por: Boueroy, Parichart, et al.
Publicado: (2017)

Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma
por: Kotepui, Kwuntida U, et al.
Publicado: (2022)

Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells
por: Saentaweesuk, Waraporn, et al.
Publicado: (2018)

Proteomic Studies of Cholangiocarcinoma and Hepatocellular Carcinoma Cell Secretomes
por: Srisomsap, Chantragan, et al.
Publicado: (2010)

O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma
por: Phoomak, Chatchai, et al.
Publicado: (2019)

Aberrant Expression of NF-κB in Liver Fluke Associated Cholangiocarcinoma: Implications for Targeted Therapy
por: Seubwai, Wunchana, et al.
Publicado: (2014)

Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma
por: Tummanatsakun, Doungdean, et al.
Publicado: (2019)

Reversine, a selective MPS1 inhibitor, induced autophagic cell death via diminished glucose uptake and ATP production in cholangiocarcinoma cells
por: Prajumwongs, Piya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ecu2a4ioq5r4rgan81tcirip4c